Bridget A. Ross - 27 Feb 2023 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role
Director
Signature
/s/ Val Gertz
Issuer symbol
LMAT
Transactions as of
27 Feb 2023
Net transactions value
-$344,890
Form type
4
Filing time
01 Mar 2023, 15:40:12 UTC
Previous filing
13 Dec 2022
Next filing
27 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Options Exercise $210,000 +7,000 +592% $30.00 8,183 27 Feb 2023 Direct F1
transaction LMAT Common Stock Sale $344,890 -7,000 -86% $49.27 1,183 27 Feb 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Stock Option (Right to Buy) Options Exercise $210,000 -7,000 -35% $30.00 13,000 27 Feb 2023 Common Stock 7,000 $30.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F2 The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $49.03 to $49.78 The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
F3 This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years.